Related Experiment Videos
[Axillary hyperhidrosis: successful treatment with botulinum toxin A]
M Heckmann1, S Breit, A Ceballos-Baumann
1Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, München.
Summary
Botulinum toxin-A (BT-A) effectively treats severe axillary hyperhidrosis by blocking sweat gland innervation. This open trial demonstrated significant sweat reduction with a well-tolerated, highly satisfying treatment option.
Area of Science:
- Dermatology
- Neurology
Context:
- Severe axillary hyperhidrosis poses significant challenges for patients and clinicians.
- Botulinum toxin-A (BT-A) is known to inhibit cholinergic sympathetic nerve activity, impacting sweat production.
Purpose:
- To evaluate the efficacy and safety of BT-A in treating severe axillary hyperhidrosis.
Summary:
- An open trial utilized BT-A (Dysport, 400 Units) injected intradermally into one axilla after hyperhidrosis visualization via iodine-starch test.
- Gravimetric sweat quantification one week post-injection showed a 91-96% reduction in sweating on the treated side.
- Unilateral treatment controlled for individual variations, demonstrating BT-A's localized anhidrotic effect. The treatment was well-tolerated and highly satisfactory for all participants.
Impact:
- BT-A presents a fast, safe, and highly effective therapeutic option for managing severe axillary hyperhidrosis.
- This study supports BT-A as a valuable tool in the clinical management of hyperhidrosis.